A Randomized, Double-blind, Placebo-Controlled, Phase 2

Project: Research project

Project Details

Description

A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Weekly Farletuzumab (MORAb-003) in Combination with Carboplatin plus Paclitaxel
StatusActive
Effective start/end date3/9/1512/31/21

Funding

  • Morphotek, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.